drugset / Trial / NCT00832455

Pediatric ACTION3 (Identify, Treat, Control): Effectiveness of Adding Montelukast in Pediatric Subjects With Uncontrolled Asthma (0476-385)

NCT00832455

Phase 4 Completed 445 enrolled Organon and Co
Non-randomizedSingle-groupOpen-labelTreatment

Summary

a study to describe patient and physician satisfaction with montelukast therapy for the control of asthma used either as monotherapy or in combination with inhaled corticosteroids

Timeline

Start
2006-06
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 4 mg Oral
Subject Montelukast Other / unclassified 5 mg Oral

Indications